Tag results:
glioblastoma
Neural Cell News
Pericytes Augment Glioblastoma Cell Resistance to Temozolomide through CCL5-CCR5 Paracrine Signaling
[Cell Research] Researchers uncovered that pericytes potentiated DNA damage repair in glioblastoma cells residing in the perivascular niche, which induced temozolomide chemoresistance.
Neural Cell News
Activating Transcription Factor 4 Mediates Adaptation of Human Glioblastoma Cells to Hypoxia and Temozolomide
[Scientific Reports] Researchers hypothesized that activating transcription factor 4 was essential for the adaptation of human glioblastoma cells to the conditions of the tumor microenvironment and contributed to therapy resistance against chemotherapy.
Cancer Stem Cell News
Molecular and Circulating Biomarkers of Brain Tumors
[International Journal of Molecular Sciences] The authors review the available literature on plasma circulating tumor cells, cell-free tumors, circulating cell-free microRNAs, and circulating extracellular vesicles for the diagnosis and monitoring of brain tumor.
Cancer Stem Cell News
Inhibiting DNA-Pk Induces Glioma Stem Cell Differentiation and Sensitizes Glioblastoma to Radiation in Mice
[Science Translational Medicine] Scientists reported that DNA-dependent protein kinase (DNA-PK) governed SOX2 stability through phosphorylation, resulting in glioma stem cell maintenance.
Immune Regulation News
SLIT2/ROBO Signaling in Tumor-Associated Microglia/Macrophages Drives Glioblastoma Immunosuppression and Vascular Dysmorphia
[Journal of Clinical Investigation] Tumor cell SLIT2 knockdown inhibited macrophage invasion and promoted a cytotoxic gene expression profile, which improved tumor vessel function and enhanced efficacy of chemotherapy and immunotherapy.
Cancer Stem Cell News
Suppression of Mitochondrial ROS by Prohibitin Drives Glioblastoma Progression and Therapeutic Resistance
[Nature Communications] Investigators discovered that prohibitin (PHB) specifically regulates mitochondrial ROS production in glioma stem-like cells (GSCs) and facilitates GSC radiotherapeutic resistance.